Simplex Trading
DNA icon

Simplex Trading’s Ginkgo Bioworks DNA Stock Holding History

Simplex Trading’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.5K Buy
+4,000
New +$33.3K ﹤0.01% 6597
2025
Q4 		– Sell
-610,000
Closed -$8.89M – 8877
2025
Q3 		$8.89M Sell
610,000
-207,800
-25% -$2.49M ﹤0.01% 1045
2025
Q2 		$9.2M Buy
817,800
+242,300
+42% +$1.88M 0.01% 943
2025
Q1 		$3.28M Sell
575,500
-356,500
-38% -$3.63M ﹤0.01% 1591
2024
Q4 		$9.15M Sell
932,000
-193,600
-17% -$1.66M 0.01% 1085
2024
Q3 		$9.17M Buy
1,125,600
+1,104,112
+5,138% +$11.1M 0.01% 1088
2024
Q2 		$287K Buy
21,488
+10,243
+91% +$306K ﹤0.01% 4290
2024
Q1 		$521K Sell
11,245
-1,828
-14% -$94.6K ﹤0.01% 3821
2023
Q4 		$868K Buy
13,073
+2,058
+19% +$126K ﹤0.01% 3139
2023
Q3 		$797K Buy
11,015
+1,612
+17% +$129K ﹤0.01% 2899
2023
Q2 		$699K Sell
9,403
-1,107
-11% -$65.5K ﹤0.01% 2959
2023
Q1 		$559K Sell
10,510
-6,515
-38% -$413K ﹤0.01% 3147
2022
Q4 		$1.15M Sell
17,025
-5,340
-24% -$491K ﹤0.01% 2334
2022
Q3 		$2.79M Buy
22,365
+18,397
+464% +$2.19M ﹤0.01% 1678
2022
Q2 		$377K Sell
3,968
-1,992
-33% -$243K ﹤0.01% 3809
2022
Q1 		$960K Sell
5,960
-1,028
-15% -$200K ﹤0.01% 2969
2021
Q4 		$2.32M Buy
+6,988
New +$3.32M ﹤0.01% 1888

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's DNA Position: Q1 2026 in Review

Simplex Trading opened a new position in Ginkgo Bioworks (DNA) in Q1 2026: 7,474 shares worth $45.8K. The stake represents ﹤0.01% of the portfolio and ranks #5969 among its holdings. This is a return to the name: Simplex Trading previously reported a position in DNA as recently as Q3 2025.

Simplex Trading first reported a position in DNA in Q1 2022 and has held it in 14 quarters since. The position peaked at $990K in Q1 2022. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Simplex Trading held 7,474 shares of Ginkgo Bioworks worth $45.8K as of Q1 2026.
  • Ginkgo Bioworks was a new Simplex Trading position in Q1 2026.
  • Ginkgo Bioworks made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5969 holding.
  • Simplex Trading first reported a position in Ginkgo Bioworks in Q1 2022 and has held it in 14 quarters since.
  • Simplex Trading's Ginkgo Bioworks position peaked at $990K in Q1 2022.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.